Rapid Micro Biosystems (RPID) Current Taxes (2020 - 2022)
Rapid Micro Biosystems (RPID) reported Current Taxes of $237000.0 for Q2 2022, down 67.22% on a YoY basis from $723000.0 in Q2 2021, and down 71.31% sequentially from $826000.0 in Q1 2022.
Rapid Micro Biosystems (RPID) Current Taxes (2020 - 2022) Analysis & Trends
Rapid Micro Biosystems (RPID) has 3 years of Current Taxes data on file, last reported at $237000.0 in Q2 2022.
- For the quarter ending Q2 2022, Current Taxes fell 67.22% year-over-year to $237000.0; the trailing twelve-month figure through Jun 2022 stood at $237000.0 (down 67.22% YoY), and the FY2021 full-year result was $781000.0, up 13.52% from the prior year.
- Current Taxes declined to $237000.0 in Q2 2022, from $826000.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $826000.0 in Q1 2022 to a low of $237000.0 in Q2 2022.
- A 3-year average of $667166.7 and a median of $735500.0 in 2021 frame the typical range for Current Taxes.
- Across the five-year window, Current Taxes increased 13.52% in 2021 and sank 67.22% in 2022, its largest moves.
- Tracing RPID's Current Taxes over 3 years: stood at $688000.0 in 2020, then rose by 13.52% to $781000.0 in 2021, then slumped by 69.65% to $237000.0 in 2022.
- Business Quant data shows RPID's Current Taxes at $237000.0 in Q2 2022, $826000.0 in Q1 2022, and $781000.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 598.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 476.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 914.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 231.81 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 194.00 Mn |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 237,000.00 |
| Mar 31, 2022 | 826,000.00 |
| Dec 31, 2021 | 781,000.00 |
| Sep 30, 2021 | 748,000.00 |
| Jun 30, 2021 | 723,000.00 |
| Dec 31, 2020 | 688,000.00 |